Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study.

Background: Quality of life assessments are important in the evaluation of new therapies for psoriasis.

Objective: To determine the effect of voclosporin (VCS) treatment on quality of life in patients with psoriasis.

Patients And Methods: 451 plaque psoriasis patients with ≥  10% body surface area involvement were randomly assigned in a double-blind fashion to 1 of 4 treatment groups (placebo, VCS 0.